RxDoctor Payments Data

Christy Oliphant, APRN

Family · Cadiz, KYNPI 1487434726

Payments from drug & device makers

$621in general payments, 2019–2025

Across 34 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$153
  • Novo Nordisk$107
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$81
  • AbbVie$55
  • Bayer$49
  • Axsome Therapeutics, Inc.$38
  • plus $137 from 6 others

What the payments were for

  • Food & beverage$621100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$621 in reported general payments places this provider in the 55th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,834
Medicare patients
19
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide18$16,813
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$15,018
FarxigaDapagliflozin Propanediol18$12,020
MounjaroTirzepatide11$10,921
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$9,387
XareltoRivaroxaban11$7,061
Albuterol Sulfate HfaAlbuterol Sulfate41$1,297
Desvenlafaxine Succinate ErDesvenlafaxine Succinate21$1,017
Atorvastatin Calcium78$491
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav46$484
Sucralfate12$474
Potassium Chloride52$473
Omeprazole52$415
Lisinopril75$396
Losartan Potassium26$383

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga$37$27,03730 claims
Novo NordiskRybelsus$107$16,81318 claims
Lilly USA, LLCMounjaro$31$10,92111 claims
GSKTrelegy Ellipta$16$9,38711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,374 family providers in Kentucky.

Other family in Cadiz

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →